Dzhumashev, D.; Timpanaro, A.; Ali, S.; De Micheli, A.J.; Mamchaoui, K.; Cascone, I.; Rössler, J.; Bernasconi, M.
Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma. Cancers 2022, 14, 5048.
https://doi.org/10.3390/cancers14205048
AMA Style
Dzhumashev D, Timpanaro A, Ali S, De Micheli AJ, Mamchaoui K, Cascone I, Rössler J, Bernasconi M.
Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma. Cancers. 2022; 14(20):5048.
https://doi.org/10.3390/cancers14205048
Chicago/Turabian Style
Dzhumashev, Dzhangar, Andrea Timpanaro, Safa Ali, Andrea J. De Micheli, Kamel Mamchaoui, Ilaria Cascone, Jochen Rössler, and Michele Bernasconi.
2022. "Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma" Cancers 14, no. 20: 5048.
https://doi.org/10.3390/cancers14205048
APA Style
Dzhumashev, D., Timpanaro, A., Ali, S., De Micheli, A. J., Mamchaoui, K., Cascone, I., Rössler, J., & Bernasconi, M.
(2022). Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma. Cancers, 14(20), 5048.
https://doi.org/10.3390/cancers14205048